Related Experiment Videos
Native pulmonary muscular proliferation
1Pathologisches Institut, Zentralkrankenhauses Gauting der LVA Oberbayern, Germany.
Abstract:
Four cases with native pulmonary muscular proliferation (NPMP) are reported. The etiology of this rare condition is unknown. A hamartomatous process is discussed. In spite of its rarity the correct diagnosis of this condition is important. Both clinically and histologically in transbronchial biopsies, NPMP may be mistaken for pulmonary lymphangioleiomyomatosis (PLAM). Distinction of these 2 conditions is adamant, as PLAM has a poor prognosis, and, moreover may be associated with general disease, as with tuberous sclerosis. Whereas the typical distribution of more mature desmin positive muscle cells in a dense center core and more immature desmin negative radiating peripheral muscle cell proliferation with fascicular pattern in NPMP may be recognized in open lung biopsy, these differences may not become evident in small transbronchial biopsies. Immunohistochemical methods play an important role in the differential diagnosis--as with PLAM estrogen and progesterone receptors may be expressed and, most importantly, the reaction of the HMB45-antibody appears consistently positive in muscle cells of PLAM, while negative with NPMP. Thus, recognition of this clinically innocent disease is also possible in small tissue particles.
Insights
Native pulmonary muscular proliferation (NPMP) is a rare lung condition that can be mistaken for pulmonary lymphangioleiomyomatosis (PLAM). Immunohistochemistry is crucial for distinguishing NPMP from PLAM, especially in small biopsies.
Area of Science:
- Pulmonary Pathology
- Histopathology
- Differential Diagnosis
Background:
- Native pulmonary muscular proliferation (NPMP) is a rare lung condition with an unknown etiology.
- NPMP can be clinically and histologically misdiagnosed as pulmonary lymphangioleiomyomatosis (PLAM) in transbronchial biopsies.
Observation:
- Distinguishing NPMP from PLAM is critical due to PLAM's poor prognosis and association with tuberous sclerosis.
- Histological differences, such as desmin staining patterns and cell distribution, may be subtle in small biopsies.
- Immunohistochemical markers, including HMB45, estrogen, and progesterone receptors, aid in differentiating NPMP from PLAM.
Findings:
- NPMP exhibits a distinct pattern of mature and immature muscle cell proliferation, often with a fascicular arrangement.
- PLAM typically shows positive staining for estrogen and progesterone receptors and consistently positive HMB45 in muscle cells.
- NPMP muscle cells are negative for HMB45.
Implications:
- Accurate diagnosis of NPMP is important as it is a clinically benign condition.
- Immunohistochemistry is essential for reliable differentiation of NPMP from PLAM in small tissue samples.
- This distinction prevents misdiagnosis and unnecessary aggressive treatment for patients with NPMP.